Overview: Macroprolactin TestIntroduction: The Macroprolactin Test measures macroprolactin to diagnose pituitary disorders, causing hormonal imbalances or fatigue. Following 2023 Endocrine Society guidelines, it uses immunoassay for high specificity, supporting endocrine screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in endocrinology for patients with suspected pituitary dysfunction.
Other Names: Macroprolactin Assay, Pituitary Hormone Test.
FDA Status: Laboratory-developed test (LDT), meeting endocrinology standards for diagnostic accuracy.
Historical Milestone: Macroprolactin testing began in the 1990s with pituitary research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures macroprolactin to diagnose pituitary disorders, guides treatment, and evaluates patients with hormonal imbalances or fatigue.
Test Parameters: 1. Macroprolactin Level
Pretest Condition: Fasting 10-12 hours required. Collect serum or plasma. Report history of hormonal imbalances, fatigue, or pituitary symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document hormonal imbalances, fatigue, infertility, or family history of pituitary disorders. Include current medications, especially dopamine agonists.
Consent: Written consent required, detailing the tests purpose, pituitary disorder implications, and risks of blood collection.
Procedural Considerations: Uses immunoassay to measure macroprolactin in serum or plasma. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for pituitary disorder diagnosis.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Non-fasting samples may reduce accuracy.
Clinical Significance: Elevated macroprolactin suggests pituitary dysfunction, guiding further evaluation or treatment. Normal levels may indicate benign macroprolactinemia.
Specialist Consultation: Consult an endocrinologist for result interpretation and treatment planning.
Additional Supporting Tests: Prolactin, pituitary MRI, or thyroid function tests to confirm pituitary disorder diagnosis.
Test Limitations: Macroprolactinemia may not always indicate pathology; clinical correlation is needed. Assay variability exists.
References: Endocrine Society Pituitary Guidelines, 2023; Journal of Clinical Endocrinology, Melmed S, 2022.
